Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Han Yu

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Plos One|November 19, 2013
Association between dietary fiber intake and physical performance in older adults: a nationwide study in TaiwanI-Chien Wu, Hsing-Yi Chang, Chih-Cheng Hsu, et al.
Current Issues in Molecular Biology|March 26, 2025
The Protective Effects of Perch Essence Against Muscle Atrophy in Cancer Cachexia and Cisplatin TreatmentShu-Lan Yeh, Pei-Yin Chen, Jiunn-Wang Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporterAnne Le, Zachary E Stine, Christopher Nguyen, et al.
Cancer Letters|April 23, 2023
Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinomaShih-Feng Yang, Meng-Tzu Weng, Ja-Der Liang, et al.
Clinical and Translational Medicine|December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisShang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary FibrosisWei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, et al.
Journal of Ethnopharmacology|March 8, 2024
Identification of anti-fibrotic and pro-apoptotic bioactive compounds from Ganoderma formosanum and their possible mechanisms in modulating TGF-β1-induced lung fibrosisKuan-Chen Cheng, Patrick Chun Theng Chong, Chen-Che Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 18, 2024
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Nature Communications|June 5, 2026
Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traitsKai-Lin Cheng, Chih-I Chen, Shu-Han Yu, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Plos One|November 19, 2013
Association between dietary fiber intake and physical performance in older adults: a nationwide study in TaiwanI-Chien Wu, Hsing-Yi Chang, Chih-Cheng Hsu, et al.
Current Issues in Molecular Biology|March 26, 2025
The Protective Effects of Perch Essence Against Muscle Atrophy in Cancer Cachexia and Cisplatin TreatmentShu-Lan Yeh, Pei-Yin Chen, Jiunn-Wang Liao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporterAnne Le, Zachary E Stine, Christopher Nguyen, et al.
Cancer Letters|April 23, 2023
Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinomaShih-Feng Yang, Meng-Tzu Weng, Ja-Der Liang, et al.
Clinical and Translational Medicine|December 23, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysisShang-Gin Wu, Chao-Chi Ho, James Chih-Hsin Yang, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
Journal of Medicinal Chemistry|July 18, 2023
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary FibrosisWei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, et al.
Journal of Ethnopharmacology|March 8, 2024
Identification of anti-fibrotic and pro-apoptotic bioactive compounds from Ganoderma formosanum and their possible mechanisms in modulating TGF-β1-induced lung fibrosisKuan-Chen Cheng, Patrick Chun Theng Chong, Chen-Che Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 18, 2024
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Nature Communications|June 5, 2026
Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traitsKai-Lin Cheng, Chih-I Chen, Shu-Han Yu, et al.
Pageof 5